Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study

Hdl Handle:
http://hdl.handle.net/10034/620602
Title:
Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study
Authors:
Agbalalah, Tari
Abstract:
Given the strong evidence for a beneficial role of vitamin D in diabetes and CVD pathogenesis, and the prevalence of vitamin D deficiency, vitamin D supplementation has been advocated for the prevention of cardiometabolic disease. To provide information on the effects of 5,000IU (125µg) vitamin D3 on cardiometabolic risk, a double blind, RCT in a cohort of overweight and obese UK adult males with plasma 25(OH)D concentration < 75nmol/L for a duration of 8 weeks was conducted. To the best of my knowledge, this is the first RCT to investigate the effect of 5,000IU (125µg) vitamin D3 on cardiometabolic markers in vitamin D insufficient, non-hypertensive and non-diabetic overweight and obese adult males.
Advisors:
Mushtaq, Sohail; Hughes, Stephen F.
Citation:
Agbalalah, T. (2017). Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study (Doctoral Dissertation). University of Chester, United Kingdom.
Publisher:
University of Chester
Publication Date:
30-Jan-2017
URI:
http://hdl.handle.net/10034/620602
Type:
Thesis or dissertation
Language:
en
Appears in Collections:
Theses

Full metadata record

DC FieldValue Language
dc.contributor.advisorMushtaq, Sohailen
dc.contributor.advisorHughes, Stephen F.en
dc.contributor.authorAgbalalah, Tarien
dc.date.accessioned2017-08-22T15:25:51Z-
dc.date.available2017-08-22T15:25:51Z-
dc.date.issued2017-01-30-
dc.identifier.citationAgbalalah, T. (2017). Vitamin D and cardiometabolic disease risk: A RCT and cross-sectional study (Doctoral Dissertation). University of Chester, United Kingdom.en
dc.identifier.urihttp://hdl.handle.net/10034/620602-
dc.description.abstractGiven the strong evidence for a beneficial role of vitamin D in diabetes and CVD pathogenesis, and the prevalence of vitamin D deficiency, vitamin D supplementation has been advocated for the prevention of cardiometabolic disease. To provide information on the effects of 5,000IU (125µg) vitamin D3 on cardiometabolic risk, a double blind, RCT in a cohort of overweight and obese UK adult males with plasma 25(OH)D concentration < 75nmol/L for a duration of 8 weeks was conducted. To the best of my knowledge, this is the first RCT to investigate the effect of 5,000IU (125µg) vitamin D3 on cardiometabolic markers in vitamin D insufficient, non-hypertensive and non-diabetic overweight and obese adult males.en
dc.language.isoenen
dc.publisherUniversity of Chesteren
dc.subjectVitamin Den
dc.subjectCardiometabolic diseaseen
dc.titleVitamin D and cardiometabolic disease risk: A RCT and cross-sectional studyen
dc.typeThesis or dissertationen
dc.rights.embargodate2018-02-22-
dc.type.qualificationnamePhDen
dc.rights.embargoreasonRecommended embargo perioden
dc.type.qualificationlevelDoctoralen
All Items in ChesterRep are protected by copyright, with all rights reserved, unless otherwise indicated.